Stocktoria
COOPER COMPANIES, INC. COO
Nasdaq · stock · Ophthalmic Goods · website · IPO 1983-01-21
COOPER COMPANIES, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.1B | $3.9B | $3.6B | $3.3B | $2.9B | $2.4B | $2.7B | $2.5B | $2.1B | $2.0B |
| Gross profit | $2.7B | $2.6B | $2.4B | $2.1B | $2.0B | $1.5B | $1.8B | $1.6B | $1.4B | $1.2B |
| R&D expense | $172.2M | $155.1M | $137.4M | $110.3M | $92.7M | $93.3M | $86.7M | $84.8M | $69.2M | $65.4M |
| SG&A expense | $1.6B | $1.5B | $1.5B | $1.3B | $1.2B | $992.5M | $996.2M | $973.3M | $799.1M | $722.8M |
| Operating income | $682.9M | $705.7M | $533.1M | $507.6M | $505.8M | $311.8M | $546.7M | $403.1M | $429.1M | $324.1M |
| Interest expense | — | — | $105.3M | $57.3M | $23.1M | $36.8M | $68.0M | $82.7M | $33.4M | $26.2M |
| Income tax | $191.6M | $190.0M | $118.7M | $89.5M | -$2.5B | $28.1M | $10.7M | $192.0M | $21.1M | $20.7M |
| Net income | $374.9M | $392.3M | $294.2M | $385.8M | $2.9B | $238.4M | $466.7M | $139.9M | $372.9M | $273.9M |
| EPS (diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $14.79 | $1.20 | $2.33 | $0.70 | $1.88 | $1.40 |
| Operating cash flow | $796.1M | $709.3M | $607.5M | $692.4M | $738.6M | $486.6M | $713.2M | $668.9M | $593.6M | $509.6M |
| Free cash flow | $433.7M | $288.1M | $215.0M | $450.4M | $524.2M | $176.2M | $421.1M | $475.3M | $466.4M | $357.0M |
| Cash & equivalents | $110.6M | $107.6M | $120.8M | $138.2M | $95.9M | $115.9M | $89.0M | $77.7M | $88.8M | $100.8M |
| Inventory | $846.0M | $802.7M | $735.6M | $628.7M | $585.6M | $570.4M | $506.9M | $468.8M | $454.1M | $417.7M |
| Total assets | $12.4B | $12.3B | $11.7B | $11.5B | $9.6B | $6.7B | $6.3B | $6.1B | $4.9B | $4.5B |
| Total liabilities | $4.2B | $4.2B | $4.1B | $4.3B | $2.7B | $2.9B | $2.6B | $2.8B | $1.7B | $1.8B |
| Shareholders' equity | $8.2B | $8.1B | $7.6B | $7.2B | $6.9B | $3.8B | $3.6B | $3.3B | $3.2B | $2.7B |
Growth · year-over-year · Revenue CAGR 8.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.1% | +8.4% | +8.6% | +13.2% | +20.2% | -8.4% | +4.8% | +18.4% | +8.8% | +9.4% |
| Net income growth | -4.4% | +33.3% | -23.7% | -86.9% | +1135.2% | -48.9% | +233.6% | -62.5% | +36.1% | +34.6% |
| EPS growth | -4.6% | +32.4% | -23.7% | -86.9% | +1129.9% | -48.4% | +232.0% | -62.6% | +34.5% | +35.0% |
| Free cash flow growth | +50.5% | +34.0% | -52.3% | -14.1% | +197.5% | -58.2% | -11.4% | +1.9% | +30.6% | +141.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.